🏆 MIT $100K Winner Revolutionizes Drug Delivery: Faster Treatments for Cancer & Autoimmune Diseases
This year’s MIT $100K Entrepreneurship Competition grand prize went to CoFlo Medical, a startup tackling a critical bottleneck in medicine: slow biologic drug delivery. Their breakthrough device injects viscous drugs 10x faster, freeing patients from hours-long IV sessions.
💉 Why This Matters
Current Challenge: Biologic drugs (for cancer, autoimmune diseases, etc.) often require 4–8-hour IV infusions due to high viscosity.
CoFlo’s Solution: A dual-fluid system that enables rapid injections (even for honey-thick drugs) without reformulation.
Impact: Faster treatment, reduced hospital time, and better access for remote areas.
Quote from Founder Simon Rufer (MIT MechE PhD Candidate):
"Patients shouldn’t be tethered to hospital beds for life-saving treatments. Our technology cuts delivery to minutes—no compromise on safety or cost."
🔬 The Science Behind It
Uses a low-viscosity fluid sheath to "lubricate" viscous drugs through needles.
Patented tech developed over 6 years at MIT.
Lab tests show 200x faster injections than current methods.
🏅 Other $100K Highlights
Haven (Founder’s Prize, $50K): AI platform for lifelong disability care planning.
Aorta Scope (3rd Place, $5K): AR-guided ultrasound for vascular surgery.
Flood Dynamics (Audience Choice): Real-time rain-flood modeling to save cities $30B/year.
#MedTech #Startup #MITInnovation #Biologics #HealthcareAccess
Comments
Post a Comment